El Granada, CA, United States of America

Wei-Jen Chung

USPTO Granted Patents = 3 

Average Co-Inventor Count = 10.0

ph-index = 1


Location History:

  • El Granada, CA (US) (2023)
  • Belmont, CA (US) (2024)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Wei-Jen Chung

Introduction

Wei-Jen Chung is a notable inventor based in El Granada, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 3 patents, his work has the potential to impact various medical treatments.

Latest Patents

Wei-Jen Chung's latest patents include innovative approaches to immune regulation. One of his key patents is for Anti-CD200R1 antibodies and methods of use thereof. This patent provides binding proteins, such as antibodies and antigen-binding fragments, that specifically bind to the human CD200R1 receptor protein. These antibodies are capable of decreasing, inhibiting, and fully blocking immune regulatory effects mediated by hu-CD200R1. Additionally, he has developed Anti-ULBP6 antibodies, which inhibit the interaction between ULBP6 and NKG2D, offering methods for treating cancer.

Career Highlights

Wei-Jen Chung is currently associated with 23andMe, Inc., where he continues to advance his research and innovations. His work is characterized by a strong focus on therapeutic applications that address critical health issues.

Collaborations

Some of his notable coworkers include Yu Chen and Jilean Beth Fenaux, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Wei-Jen Chung's contributions to biotechnology through his patents and research are paving the way for new therapeutic strategies. His work exemplifies the innovative spirit that drives advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…